Canada has entered Phase 2 clinical trials of AeroVax, an inhaled Covid-19 vaccine developed by researchers at McMaster University. Unlike traditional injected vaccines, AeroVax is designed to be ...

Experts say small changes in our neighborhoods—like where we sit, walk, or congregate—can make a big difference in how ...

Our lungs are fairly susceptible to diseases. Unlike most other organs, the lungs are in direct contact with the outside ...

The company’s turbines — enough to power 280,000 homes — run without emission controls in an area that leads Tennessee in ...

Scaling productivity for health care providers,” highlights how generative artificial intelligence (AI) can offer a critical ...

To mark World Asthma Day 2025, the Global Asthma Network (GAN) launches the Global Asthma Report 2025: Patient Stories , a compelling collection of ...

Asthma is one of the most common chronic respiratory conditions worldwide, and its impact is increasingly felt in the UAE due ...

Abundant, low-cost, clean energy—the envisioned result if scientists and engineers can successfully produce a reliable method ...

SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.